|Articles|December 20, 2001
CBER Recall of Hepatitis A Vaccine
Author(s)BioPharm International Editors
CBER Recall of Hepatitis A Vaccine, Inactivated (VAQTA) Packaged in single-dose prefilled syringes, posted 10 December 2001
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
4
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
5
